Keyphrases
Malignancy
100%
Tumor Necrosis Factor-α
100%
Inflammatory Bowel Disease
100%
Biological Agents
100%
Multicenter Cohort Study
100%
Comparative Safety
100%
Tumor Necrosis Factor Antagonist
100%
Nontumor
100%
Incidence Rate
66%
Hazard Ratio
33%
Follow-up Examination
33%
Recurrence-free Survival
33%
Progression-free Survival
33%
Prior Cancer
33%
Active Cancer
33%
Solid Organ Malignancy
33%
Propensity Score
16%
Cancer Tumor
16%
Disease Severity
16%
Cancer Progression
16%
Remission
16%
Oncologists
16%
Recurrence Risk
16%
Cancer Diagnosis
16%
Cancer Recurrence
16%
Risk of Progression
16%
Multicenter Retrospective Cohort Study
16%
Inverse Probability of Treatment Weighting
16%
Medicine and Dentistry
Cancer
100%
Patient with Inflammatory Bowel Disease
100%
Tumor Necrosis Factor
100%
Biological Product
100%
Cohort Analysis
100%
Malignant Neoplasm
58%
Hazard Ratio
16%
Progression Free Survival
16%
Recurrence Free Survival
16%
Disease Severity
8%
Retrospective Cohort Study
8%
Cancer Growth
8%
Oncologist
8%
Cancer Diagnosis
8%
Cancer Recurrence
8%
Inflammatory Bowel Disease
8%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Necrosis Factor
100%
Inflammatory Bowel Disease
100%
Biological Product
100%
Cohort Study
100%
Malignant Neoplasm
66%
Progression Free Survival
16%
Recurrence Free Survival
16%
Remission
8%
Cancer Growth
8%
Disease Severity
8%
Cancer Recurrence
8%